Hyperfine (HYPR) Total Debt (2020 - 2026)

Name: Hyperfine (HYPR) Total Debt (2020 - 2026) | Business Quant
Creator: Business Quant

Hyperfine posted quarterly Total Debt of $13.1 million for Q1 2026, up 20404.69% on a QoQ basis from $64000.0 in Q1 2023.

Hyperfine (HYPR) has 5 years of Total Debt data on file, last reported at $13.1 million in Q1 2026.

For the quarter ending Q1 2026, Total Debt changed N/A year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (changed N/A YoY), and the FY2021 full-year result was $2.0 million, up 530.89% from the prior year.
Total Debt for Q1 2026 stood at $13.1 million, up from $64000.0 in the prior quarter.
Across five years, Total Debt topped out at $13.1 million in Q1 2026 and bottomed at $61000.0 in Q3 2022.
The 3-year median for Total Debt is $81000.0 (2022), against an average of $2.7 million.
Peak annual rise in Total Debt reached 34.02% in 2023, while the deepest fall reached 34.02% in 2023.
A 3-year view of Total Debt shows it stood at $61000.0 in 2022, then climbed by 4.92% to $64000.0 in 2023, then soared by 20404.69% to $13.1 million in 2026.
The last three Total Debt figures came in at $13.1 million (Q1 2026), $64000.0 (Q1 2023), and $61000.0 (Q3 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	34.05 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.72 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	10.13 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	1.93 Bn
10	Hyperfine	149.47 Mn	108.20 Mn	1.98 Mn	13.12 Mn

Download Data 🔒